This is in line with Kurose et al.'s study reporting that serum Gal-9 levels are elevated in the patients with type 2 diabetes (T2DM) and chronic kidney disease (CKD) [57]. This evidence concerns the gene LGALS9 and type 2 diabetes mellitus.